Author:
Sheets Rebecca L.,Stein Judith,Manetz T. Scott,Duffy Chris,Nason Martha,Andrews Charla,Kong Wing-Pui,Nabel Gary J.,Gomez Phillip L.
Publisher
Oxford University Press (OUP)
Reference19 articles.
1. Barouch, D., Truitt, D. M., and Letvin, N. L. (2004). Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant. Vaccine22,3092–3097.
2. Barouch, D., Yang, Z.-Y., Kong, W.-P., Korioth-Schmitz, B., Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Miura, A., Mascola, J. R., et al. (2005). An HTLV-1 regulatory element enhances the immunogenicity of HIV-1 DNA vaccines in mice and nonhuman primates. J. Virol.79,9694–9701.
3. CBER. (1996). Points to Consider on Plasmid DNA Vaccines for Preventive Infectious Disease Indications. CBER.
4. CBER. (2005). Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications. CBER.
5. Chakrabarti, B. K., Kong, W.-P., Wu, B.-Y., Yang, Z.-Y., Friborg, J., Ling, X., King, S. R., Montifiori, D. C., and Nabel, G. J. (2002). Modifications of the human immunodeficiency virus envelope glycoprotein enhances immunogenicity for genetic immunization. J. Virol.76,5357–5368.
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献